MP Biomedicals New Zealand Ltd (MP Bio) is a specialized manufacturer of high-quality bovine proteins and has gained an international reputation in providing bovine plasma proteins to the global bio-pharmaceutical, animal health and diagnostic industry, and to prominent research institutes in New Zealand and abroad for various mammalian cell culture research and embryo transfer applications.
04 September 2019
Argenta Limited, a New Zealand animal health company, has worked with Medicines Development for Global Health (MDGH), a not-for-profit Australian biopharmaceutical company, to gain US Federal Drug Administration (FDA) approval of an innovative treatment for river blindness.
28 June 2018
A new diagnostic test using a few drops of blood could be used detect Alzheimer’s disease years before symptoms begin to show. By 2050 more than 170,000 New Zealanders are forecast to have dementia – the majority of which will be Alzheimer’s.
01 February 2018
A pericardium looks more like a cheese slice than high-value biomaterial suitable for repairing human hearts.
24 January 2018
Some medicinal cannabis users say they can see hope but no material changes for them in the government’s proposed legislation.
21 December 2017
Living Cell Technologies Limited has filed a provisional patent for pericyte protective agents titled “PERICYTE PROTECTIVE AGENTS FOR NEUROLOGICAL DISORDERS INCLUDING NEURODEGENERATIVE DISEASES, CENTRAL NERVOUS SYSTEM DISEASES AND OTHERS”.
08 November 2017
Follow the link to listen to Andrew Pattersons interview with Dr Clyde Smith starts at 22:30
23 October 2017
A handheld gadget used to scan for diseases in the sci-fi series Star Trek could soon become reality, with a new Kiwi study targeting our high rates of skin cancer.
26 September 2017
Current healthcare trends would be witnessing more changes (or disruptions) as the impact of the Fourth Industrial Revolution (4IR) takes effect worldwide.
13 September 2017
